Characterisation of gastrointestinal and thoracic neuroendocrine tumours

被引：0

作者：

Baudin, E. ^{[1
]}

Scoazec, J. -Y. ^{[1
]}

Caramella, C. ^{[1
]}

Leboulleux, S. ^{[1
]}

Caron, O. ^{[1
]}

Deandreis, D. ^{[1
]}

Duvillard, P. ^{[1
]}

Lumbroso, J. ^{[1
]}

de Baere, T. ^{[1
]}

Deschamps, F. ^{[1
]}

Goere, D. ^{[1
]}

Dumont, F. ^{[1
]}

Elias, D. ^{[1
]}

Malka, D. ^{[1
]}

Boige, V. ^{[1
]}

Schlumberger, M. ^{[1
]}

Guigay, J. ^{[1
]}

Planchard, D. ^{[1
]}

Ducreux, M. ^{[1
]}

机构：

[1] Gustave Roussy, Ctr Expert RENATEN Tumeurs Neuroendocrines, F-94805 Villejuif, France

来源：

ONCOLOGIE | 2013年 / 15卷 / 10-11期

关键词：

Neuroendocrine tumours; Prognosis factors; Diagnostic impact; Characterisation; Response to treatment; Multidisciplinary expertise; RENATEN and TENPATH networks; ENETS CONSENSUS GUIDELINES; PROGNOSTIC-FACTORS; ENDOCRINE TUMORS; MANAGEMENT; NEOPLASMS;

D O I：

10.1007/s10269-013-2343-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Once the diagnosis of a neuroendocrine tumour has been made, characterisation is an essential step before therapy. It comes before the decision regarding treatment is made. This requires a multidisciplinary team of experts located in specialist centres that currently make up the RENATEN and TENPATH networks. It is directed by knowledge of the location of the primary tumour and anatomical pathological differentiation. The aim of this characterisation step is to highlight factors that may have an impact on the diagnosis and the prognosis or predict the response to treatment.

引用

页码：505 / 509

页数：5

共 50 条

[31] Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type
Siddiqa, Ayesha
Adel, Hatem
Khan, Sohail Ahmed
Huda, Farheen
Sattar, Amjad
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2019, 69 (04) : 533 - 540
[32] Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis
Walter, Martin A.
Nesti, Cedric
Spanjol, Marko
Kollar, Attila
Buetikofer, Lukas
Gloy, Viktoria L.
Dumont, Rebecca A.
Seiler, Christian A.
Christ, Emanuel R.
Radojewski, Piotr
Briel, Matthias
Kaderli, Reto M.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (11):
[33] Time to give up traditional methods for the management of gastrointestinal neuroendocrine tumours
Ahmet Yozgat
Murat Kekilli
Mustafa Altay
World Journal of Clinical Cases, 2021, 9 (29) : 8627 - 8646
[34] Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract
Klöppel, G
Anlauf, M
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (04) : 507 - 517
[35] Exploring Gastrointestinal Symptoms and Their Impact on Quality of Life in Patients with Neuroendocrine Tumours
Williams, M.
Reid, K.
Ng, S.
Benny, A.
Lewis, J.
Sunderraj, L.
Williams, H.
Rees, A.
Khan, M.
NEUROENDOCRINOLOGY, 2016, 103 : 120 - 121
[36] Evaluation of Ki67 stained neuroendocrine tumours of the gastrointestinal tract
Mola, N.
Hodneland, E.
Krasontovitsch, V.
Leh, S.
VIRCHOWS ARCHIV, 2020, 477 : S202 - S202
[37] Neuroendocrine tumours of the gastrointestinal tract: a retrospective evaluation and reclassification of 69 cases
Sahin, H.
Celikel, C.
VIRCHOWS ARCHIV, 2018, 473 : S239 - S239
[38] Time to give up traditional methods for the management of gastrointestinal neuroendocrine tumours
Yozgat, Ahmet
Kekilli, Murat
Altay, Mustafa
WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (29) : 8627 - 8646
[39] Neuroendocrine tumours
Mignon, M
Rigaud, D
Lebtahi, R
Sassolas, G
Urbain, JL
Metman, E
Abdelli, N
Baulieu, F
Askienazy, S
Paycha, F
Huglo, D
Denis, J
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 1996, 20 (4-5): : 316 - 321
[40] Neuroendocrine tumours
Barakat, MT
Meeran, K
Bloom, SR
ENDOCRINE-RELATED CANCER, 2004, 11 (01) : 1 - 18

← 1 2 3 4 5 →